Alexion Pharmaceuticals expands in Dublin, to add 200 jobs
Alexion Pharmaceuticals will significantly expand its operations in Ireland by constructing the company's first ever biologics manufacturing facility outside the U.S. This $502.6 million, four-year project, which will be constructed at Alexion's College Park site in Blanchardstown, is expected to create approximately 200 additional full-time jobs on completion, bringing Alexion's total workforce in Ireland to almost 500.
Since entering Ireland in 2013, Alexion has invested $145.2 million in two facilities—a vial fill-finish facility in Athlone and a global supply chain facility at College Park. Phase I of the College Park facility, comprising Global Supply Chain HQ, laboratories, packaging and warehousing operations, is expected to be operational by yearend.